Sarah Deleu

482 total citations
9 papers, 262 citations indexed

About

Sarah Deleu is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Sarah Deleu has authored 9 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Hematology and 4 papers in Oncology. Recurrent topics in Sarah Deleu's work include Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Sarah Deleu is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Sarah Deleu collaborates with scholars based in Belgium, United States and United Kingdom. Sarah Deleu's co-authors include Karin Vanderkerken, Miguel Lemaire, Eline Menu, Els Van Valckenborgh, Isabelle Vande Broek, Elke De Bruyne, Hendrik De Raeve, Janine Arts, Peter I. Croucher and Mårten Fryknäs and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Sarah Deleu

8 papers receiving 262 citations

Peers

Sarah Deleu

MB

HEMAT

ONCOL

CR

IMMUN

Elodie Odore France

A. Keith Stewart United States

Jonathan M. Ahmann United States

Júlia Aguadé-Gorgorió Switzerland

Evžen Gregora Czechia

Mrinal Y. Shah United States

Mohammad Alzrigat Sweden

Jean‐Richard Saint‐Martin United States

D. Carrera Spain

Mays Jawad United Kingdom

Elodie Odore France

Sarah Deleu

334 ×1.6

MB

143 ×1.0

HEMAT

57 ×0.6

ONCOL

19 ×0.9

CR

12 ×0.6

IMMUN

Citations per year, relative to Sarah Deleu Sarah Deleu (= 1×) peers Elodie Odore

Countries citing papers authored by Sarah Deleu

Since Specialization

Citations

This map shows the geographic impact of Sarah Deleu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Deleu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Deleu more than expected).

Fields of papers citing papers by Sarah Deleu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Deleu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Deleu. The network helps show where Sarah Deleu may publish in the future.

Co-authorship network of co-authors of Sarah Deleu

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Deleu. A scholar is included among the top collaborators of Sarah Deleu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Deleu. Sarah Deleu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Lemaire, Miguel, Sarah Deleu, Elke De Bruyne, et al.. (2011). The Microenvironment and Molecular Biology of the Multiple Myeloma Tumor. Advances in cancer research. 110. 19–42. 60 indexed citations

2.

Kalushkova, Antonia, Mårten Fryknäs, Miguel Lemaire, et al.. (2010). Polycomb Target Genes Are Silenced in Multiple Myeloma. PLoS ONE. 5(7). e11483–e11483. 76 indexed citations

3.

Deleu, Sarah, Miguel Lemaire, Janine Arts, et al.. (2009). The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor, on the development of multiple myeloma in the 5T2MM and 5T33MM murine models. Leukemia. 23(10). 1894–1903. 47 indexed citations

4.

Deleu, Sarah, Miguel Lemaire, Janine Arts, et al.. (2009). Bortezomib Alone or in Combination with the Histone Deacetylase Inhibitor JNJ-26481585: Effect on Myeloma Bone Disease in the 5T2MM Murine Model of Myeloma. Cancer Research. 69(13). 5307–5311. 57 indexed citations

5.

Deleu, Sarah, Eline Menu, Els Van Valckenborgh, et al.. (2009). Histone deacetylase inhibitors in multiple myeloma. Hematology Reports. 1(1). 9–9. 8 indexed citations

6.

Vanderkerken, Karin, Elke De Bruyne, Sarah Deleu, et al.. (2009). Epigenetic Regulation of Multiple Myeloma Within its Bone Marrow Microenvironment. Clinical Lymphoma & Myeloma. 9. S29–S30.

7.

Fraczek, Joanna, Sarah Deleu, Tatyana Y. Doktorova, et al.. (2008). Screening of amide analogues of Trichostatin A in cultures of primary rat hepatocytes: search for potent and safe HDAC inhibitors. Investigational New Drugs. 27(4). 338–346. 10 indexed citations

8.

Deleu, Sarah, Joanna Fraczek, Dirk Tourwé, et al.. (2008). Screening of Trichostatin Analogues Based on Cellular Potency in the Murine Multiple Myeloma 5T33MM Model. 4(2008). 117–121. 2 indexed citations

9.

Bruyne, Elke De, Tomas Bos, Sarah Deleu, et al.. (2007). Regulation of Bim Expression by IGF-1 in the 5T33MM Murine Model for Multiple Myeloma.. Blood. 110(11). 3512–3512. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact